{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T17:23:11Z","timestamp":1764350591145},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,11,12]]},"DOI":"10.7759\/cureus.11457","type":"journal-article","created":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T18:23:02Z","timestamp":1605205382000},"source":"Crossref","is-referenced-by-count":2,"title":["Complete Remission from Salvage Volumetric Modulated Arc Therapy in Recurrent Adenocarcinoma of the Jejunum with Retroperitoneal Metastasis Eleven Years after Diagnosis: A Rare Case of Cure"],"prefix":"10.7759","author":[{"given":"Ming","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"National Cancer Institute. SEER cancer stat facts: small intestine cancer. (2020). Accessed: October 27, 2020: https:\/\/seer.cancer.gov\/statfacts\/html\/smint.html."},{"key":"ref2","article-title":"The American College of Surgeons commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995","volume":"86","author":"Howe JR","year":"1999","unstructured":"Howe JR, Karnell LH, Menck HR, Scott-Conner C. The American College of Surgeons commission on Cancer and the American Cancer Society. Adenocarcinoma of the small bowel: review of the National Cancer Data Base, 1985-1995. Cancer. 1999, 86:2693-2706.","journal-title":"Cancer"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e328350dd0d","article-title":"A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma","volume":"23","author":"Xiang XJ","year":"2012","unstructured":"Xiang XJ, Liu YW, Zhang L, et al.. A phase II study of modified FOLFOX as first-line chemotherapy in advanced small bowel adenocarcinoma. Anticancer Drugs. 2012, 23:561-566. 10.1097\/CAD.0b013e328350dd0d","journal-title":"Anticancer Drugs"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s10147-017-1138-6","article-title":"A phase II study of 5-fluorouracil\/L-leucovorin\/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma","volume":"22","author":"Horimatsu T","year":"2017","unstructured":"Horimatsu T, Nakayama N, Moriwaki T, et al.. A phase II study of 5-fluorouracil\/L-leucovorin\/oxaliplatin (mFOLFOX6) in Japanese patients with metastatic or unresectable small bowel adenocarcinoma. Int J Clin Oncol. 2017, 22:905-912. 10.1007\/s10147-017-1138-6","journal-title":"Int J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.30766","article-title":"North Central Cancer Treatment Group N0543 (Alliance): a phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma","volume":"123","author":"McWilliams RR","year":"2017","unstructured":"McWilliams RR, Foster NR, Mahoney MR, et al.. North Central Cancer Treatment Group N0543 (Alliance): a phase 2 trial of pharmacogenetic-based dosing of irinotecan, oxaliplatin, and capecitabine as first-line therapy for patients with advanced small bowel adenocarcinoma. Cancer. 2017, 123:3494-3501. 10.1002\/cncr.30766","journal-title":"Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25614","article-title":"Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study","volume":"117","author":"Zaanan A","year":"2011","unstructured":"Zaanan A, Gauthier M, Malka D, et al.. Second-line chemotherapy with fluorouracil, leucovorin, and irinotecan (FOLFIRI regimen) in patients with advanced small bowel adenocarcinoma after failure of first-line platinum-based chemotherapy: a multicenter AGEO study. Cancer. 2011, 117:1422-1428. 10.1002\/cncr.25614","journal-title":"Cancer"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinre.2015.09.008","article-title":"Advanced small bowel adenocarcinoma: molecular characteristics and therapeutic perspectives","volume":"40","author":"Zaaimi Y","year":"2016","unstructured":"Zaaimi Y, Aparicio T, Laurent-Puig P, Taieb J, Zaanan A. Advanced small bowel adenocarcinoma: molecular characteristics and therapeutic perspectives. Clin Res Hepatol Gastroenterol. 2016, 40:154-160. 10.1016\/j.clinre.2015.09.008","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.dld.2017.09.123","article-title":"Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO)","volume":"50","author":"Locher C","year":"2018","unstructured":"Locher C, Batumona B, Afchain P, et al.. Small bowel adenocarcinoma: French intergroup clinical practice guidelines for diagnosis, treatments and follow-up (SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO). Dig Liver Dis. 2018, 50:15-19. 10.1016\/j.dld.2017.09.123","journal-title":"Dig Liver Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.25324","article-title":"Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database","volume":"116","author":"Overman MJ","year":"2010","unstructured":"Overman MJ, Hu CY, Wolff RA, Chang GJ. Prognostic value of lymph node evaluation in small bowel adenocarcinoma: analysis of the surveillance, epidemiology, and end results database. Cancer. 2010, 116:5374-5382. 10.1002\/cncr.25324","journal-title":"Cancer"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2016.09.027","article-title":"Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: a matched cohort study","volume":"69","author":"Ecker BL","year":"2016","unstructured":"Ecker BL, McMillan MT, Datta J, et al.. Lymph node evaluation and survival after curative-intent resection of duodenal adenocarcinoma: a matched cohort study. Eur J Cancer. 2016, 69:135-141. 10.1016\/j.ejca.2016.09.027","journal-title":"Eur J Cancer"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.6004\/jnccn.2019.0043","article-title":"Small bowel adenocarcinoma, version 1.2020, NCCN clinical practice guidelines in oncology","volume":"17","author":"Benson AB","year":"2019","unstructured":"Benson AB, Venook AP, Al-Hawary MM, et al.. Small bowel adenocarcinoma, version 1.2020, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2019, 17:1109-1133. 10.6004\/jnccn.2019.0043","journal-title":"J Natl Compr Canc Netw"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s11864-018-0592-3","article-title":"Management of advanced small bowel cancer","volume":"19","author":"Puccini A","year":"2018","unstructured":"Puccini A, Battaglin F, Lenz HJ. Management of advanced small bowel cancer. Curr Treat Options Oncol. 2018, 19:69. 10.1007\/s11864-018-0592-3","journal-title":"Curr Treat Options Oncol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.29840","article-title":"Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: a propensity score-matched analysis","volume":"122","author":"Ecker BL","year":"2016","unstructured":"Ecker BL, McMillan MT, Datta J, et al.. Efficacy of adjuvant chemotherapy for small bowel adenocarcinoma: a propensity score-matched analysis. Cancer. 2016, 122:693-701. 10.1002\/cncr.29840","journal-title":"Cancer"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2017.338","article-title":"The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study","volume":"117","author":"Sakae H","year":"2017","unstructured":"Sakae H, Kanzaki H, Nasu J, et al.. The characteristics and outcomes of small bowel adenocarcinoma: a multicentre retrospective observational study. Br J Cancer. 2017, 117:1607-1613. 10.1038\/bjc.2017.338","journal-title":"Br J Cancer"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjsurg.2009.05.037","article-title":"A single-institution experience with 491 cases of small bowel adenocarcinoma","volume":"199","author":"Halfdanarson TR","year":"2010","unstructured":"Halfdanarson TR, McWilliams RR, Donohue JH, Quevedo JF. A single-institution experience with 491 cases of small bowel adenocarcinoma. Am J Surg. 2010, 199:797-803. 10.1016\/j.amjsurg.2009.05.037","journal-title":"Am J Surg"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-11-205","article-title":"Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study","volume":"11","author":"Koo DH","year":"2011","unstructured":"Koo DH, Yun SC, Hong YS, et al.. Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study. BMC Cancer. 2011, 11:205. 10.1186\/1471-2407-11-205","journal-title":"BMC Cancer"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-015-1014-6","article-title":"Prognostic factors and treatment outcomes in patients with small bowel adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experience","volume":"15","author":"Khan K","year":"2015","unstructured":"Khan K, Peckitt C, Sclafani F, et al.. Prognostic factors and treatment outcomes in patients with small bowel adenocarcinoma (SBA): the Royal Marsden Hospital (RMH) experience. BMC Cancer. 2015, 15:15. 10.1186\/s12885-015-1014-6","journal-title":"BMC Cancer"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1634\/theoncologist.2012-0079","article-title":"Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy","volume":"17","author":"Tsushima T","year":"2012","unstructured":"Tsushima T, Taguri M, Honma Y, et al.. Multicenter retrospective study of 132 patients with unresectable small bowel adenocarcinoma treated with chemotherapy. Oncologist. 2012, 17:1163-1170. 10.1634\/theoncologist.2012-0079","journal-title":"Oncologist"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1080\/02656736.2016.1266700","article-title":"Treatment of peritoneal metastases from small bowel adenocarcinoma","volume":"33","author":"Rovers KP","year":"2017","unstructured":"Rovers KP, de Bree E, Yonemura Y, de Hingh IH. Treatment of peritoneal metastases from small bowel adenocarcinoma. Int J Hyperthermia. 2017, 33:571-578. 10.1080\/02656736.2016.1266700","journal-title":"Int J Hyperthermia"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-018-6369-x","article-title":"Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal metastases from a small bowel adenocarcinoma: multi-institutional experience","volume":"25","author":"Liu Y","year":"2018","unstructured":"Liu Y, Yonemura Y, Levine EA, et al.. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy for peritoneal metastases from a small bowel adenocarcinoma: multi-institutional experience. Ann Surg Oncol. 2018, 25:1184-1192. 10.1245\/s10434-018-6369-x","journal-title":"Ann Surg Oncol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/45226-complete-remission-from-salvage-volumetric-modulated-arc-therapy-in-recurrent-adenocarcinoma-of-the-jejunum-with-retroperitoneal-metastasis-eleven-years-after-diagnosis-a-rare-case-of-cure","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:19:59Z","timestamp":1707506399000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/45226-complete-remission-from-salvage-volumetric-modulated-arc-therapy-in-recurrent-adenocarcinoma-of-the-jejunum-with-retroperitoneal-metastasis-eleven-years-after-diagnosis-a-rare-case-of-cure"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,12]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.11457","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2020,11,12]]}}}